TAK-925: Clinical Trials

8 trials of TAK-925, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 terminated. 7 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Completed 7
Phase 21Terminated 1

Follow TAK-925: new trials by email Literature Review of TAK-925 trials Research Report on TAK-925

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal Surgery
Danavorexton, Placebo - Sleep Apnea
Phase 2TerminatedTakeda412023-05-112025-09-16
A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea
Danavorexton, Placebo - Sleep Apnea
Phase 1CompletedTakeda132022-03-102022-12-02
A Study of Danavorexton in Anesthetized Adults
Danavorexton, Danavorexton Placebo, Propofol - Healthy Volunteers
Phase 1CompletedTakeda282021-09-282022-05-10
A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia
TAK-925, TAK-925 Placebo - Idiopathic Hypersomnia
Phase 1CompletedMillennium Pharmaceuticals, Inc.282020-01-262023-09-26
Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP)
TAK-925, Placebo - Obstructive Sleep Apnea
Phase 1CompletedMillennium Pharmaceuticals, Inc.252019-11-212020-04-20
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy
TAK-925, Placebo - Healthy Participants, Narcolepsy
Phase 1CompletedTakeda572018-11-212020-12-08
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults
TAK-925, TAK-925 Placebo, Modafinil - Healthy Volunteers
Phase 1CompletedTakeda202018-05-092021-03-26
Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy
TAK-925, Placebo - Healthy Participants and Patients With Narcolepsy
Phase 1CompletedTakeda582017-11-042021-03-30

Conditions studied

Sleep Apnea Syndromes (2)  ·  Sleep Apnea, Obstructive (2)  ·  Idiopathic Hypersomnia (1)  ·  Narcolepsy (1)

Sponsors

Takeda (6)  ·  Millennium Pharmaceuticals, Inc. (2)

Countries

United States (5)  ·  Japan (3)  ·  Australia (1)

Results publications

PMID 36883238, PMID 36934366, PMID 38296753